Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (67)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mousa, H. A.
Right arrow Articles by Alfirevic1, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mousa, H. A.
Right arrow Articles by Alfirevic1, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 8, 1830-1833, August 2000
© 2000 European Society of Human Reproduction and Embryology

Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

Hatem A. Mousa and Zarko Alfirevic11

University Department of Obstetrics and Gynaecology, Liverpool Women's Hospital, UK

We examined the relationship between placental histology and thrombophilia status in women who were admitted with severe pre-eclampsia/eclampsia, placental abruption, intrauterine growth restriction or unexplained stillbirth. All women had thrombophilia screen at least 10 weeks after delivery (antithrombin III, protein C, protein S, activated protein C resistance, anticardiolipin antibodies, lupus anticoagulant, fasting plasma homocysteine and specific mutations to methylenetetrahydrofolate reductase C677T, G20210A prothrombin gene and factor V Leiden. Placental histology reports were examined to identify the frequency of thrombotic lesions in the placenta including fetal stem vessel thrombosis, fetal thrombotic vasculopathy, placental infarction, perivillous fibrin deposition, intervillous thrombosis and placental floor infarction. During a 17 month period, a cohort of 79 women met the study criteria. Thirty (70%) out of 43 women with abnormal thrombophilia screen had abnormal placental histology. Twenty-eight (78%) out of 36 women with negative thrombophilia screen had abnormal placentae. No specific histological pattern could be identified when thrombophilia positive and thrombophilia negative groups were compared. We propose that there is a poor correlation between thrombophilia status and pathological changes of the placenta in women with severe pregnancy complications.

Key words: adverse pregnancy outcome/placental thrombosis/thrombophilia

1 To whom correspondence should be addressed at: University Department of Obstetrics and Gynaecology, University of Liverpool, Liverpool L69 3BX, UK. E-mail: zarko{at}liv.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
C. V. Ananth and S. Cnattingius
Influence of Maternal Smoking on Placental Abruption in Successive Pregnancies: A Population-based Prospective Cohort Study in Sweden
Am. J. Epidemiol., August 1, 2007; 166(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Sood, M. Zogg, R. J. Westrick, Y.-h. Guo, E. J. Kerschen, G. Girardi, J. E. Salmon, S. R. Coughlin, and H. Weiler
Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers
J. Exp. Med., May 14, 2007; 204(5): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Sood, S. Kalloway, A. E. Mast, C. J. Hillard, and H. Weiler
Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells
Blood, April 15, 2006; 107(8): 3173 - 3180.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Cattaneo
Homocysteine and the Risk of Intrauterine Growth Retardation
Clin. Chem., September 1, 2003; 49(9): 1432 - 1433.
[Full Text] [PDF]


Home page
NEJMHome page
M. J. Kupferminc, A. Many, J. B. Lessing, E. Grandone, M. Margaglione, C. Infante-Rivard, G.-E. Rivard, and R. Gauthier
Thrombophilia Polymorphisms and Intrauterine Growth Restriction
N. Engl. J. Med., November 7, 2002; 347(19): 1530 - 1531.
[Full Text] [PDF]


Home page
NEJMHome page
D. Roberts and R. S. Schwartz
Clotting and Hemorrhage in the Placenta -- A Delicate Balance
N. Engl. J. Med., July 4, 2002; 347(1): 57 - 59.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R. Rai, M. Backos, S. Elgaddal, A. Shlebak, and L. Regan
Factor V Leiden and recurrent miscarriage--prospective outcome of untreated pregnancies
Hum. Reprod., February 1, 2002; 17(2): 442 - 445.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N.J. Sebire
Thrombophilias and adverse pregnancy outcome
Hum. Reprod., February 1, 2001; 16(2): 395 - 395.
[Full Text] [PDF]


Home page
Hum ReprodHome page
T.Y. Khong, L. Moore, and W.M. Hague
Thrombophilias and adverse pregnancy outcome
Hum. Reprod., February 1, 2001; 16(2): 395 - 396.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.